雲天勵飛(688343.SH):嚕咔博士是一家致力於AI智能硬件創新的品牌
格隆匯12月3日丨雲天勵飛(688343.SH)在投資者互動平台表示,嚕咔博士是一家致力於AI智能硬件創新的品牌,專注於為兒童打造探索世界的新時代AI工具,即將於12月正式推出大模型原生教育硬件。該產品針對3歲以上兒童設計,內置領先的多模態大模型,涵蓋知識科普、語言啟蒙、藝術創造及趣味故事等功能,讓孩子在娛樂中學習、在玩耍中提升認知,激發興趣潛能。嚕咔博士與浩方集團正式簽署戰略合作協議,雙方將在中國創新AI產品出海領域展開深度合作,共同探索在全球市場上打造中國AI硬件品牌的新路徑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.